AU4388899A - Novel compositions for the treatment of atherosclerosis and related conditions - Google Patents

Novel compositions for the treatment of atherosclerosis and related conditions

Info

Publication number
AU4388899A
AU4388899A AU43888/99A AU4388899A AU4388899A AU 4388899 A AU4388899 A AU 4388899A AU 43888/99 A AU43888/99 A AU 43888/99A AU 4388899 A AU4388899 A AU 4388899A AU 4388899 A AU4388899 A AU 4388899A
Authority
AU
Australia
Prior art keywords
atherosclerosis
treatment
related conditions
novel compositions
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43888/99A
Inventor
Michael Aviram
Bianca Fuhrman
Mira Rosenblat
Meir Tenne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DALIDAR PHARMA ISRAEL (1995) Ltd
TEFF JENNIFER
Original Assignee
DALIDAR PHARMA ISRAEL 1995 Ltd
JENNIFER TEFF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DALIDAR PHARMA ISRAEL 1995 Ltd, JENNIFER TEFF filed Critical DALIDAR PHARMA ISRAEL 1995 Ltd
Publication of AU4388899A publication Critical patent/AU4388899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU43888/99A 1998-07-13 1999-06-22 Novel compositions for the treatment of atherosclerosis and related conditions Abandoned AU4388899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL125316 1998-07-13
IL12531698A IL125316A0 (en) 1998-07-13 1998-07-13 Novel compositions for treatment of atherosclerosis and related conditions
PCT/IL1999/000342 WO2000002569A2 (en) 1998-07-13 1999-06-22 Compositions for the treatment of atherosclerosis and related conditions

Publications (1)

Publication Number Publication Date
AU4388899A true AU4388899A (en) 2000-02-01

Family

ID=11071735

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43888/99A Abandoned AU4388899A (en) 1998-07-13 1999-06-22 Novel compositions for the treatment of atherosclerosis and related conditions

Country Status (5)

Country Link
EP (1) EP1121138A2 (en)
AU (1) AU4388899A (en)
CA (1) CA2337753A1 (en)
IL (1) IL125316A0 (en)
WO (1) WO2000002569A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI290469B (en) * 2000-07-12 2007-12-01 Medical & Pharm Ind Tech & Dev Method for manufacturing product with component capable of efficiently preventing inflammation and platelets agglutination form ginger and medical composition with the efficient component
CN109512803B (en) * 2018-12-10 2021-08-24 广州医科大学附属第二医院 Agonist of adenylate activated protein kinase and application thereof
CN113925948B (en) * 2020-07-14 2023-10-10 香港大学 Use of rhizoma Zingiberis recens total extract or its active component, pharmaceutical composition and preparation method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6372625A (en) * 1986-09-12 1988-04-02 Tsumura & Co Blood platelet agglutination inhibitor
JP3164455B2 (en) * 1993-02-18 2001-05-08 ポーラ化成工業株式会社 Stratum corneum repair promoter
CN1110523A (en) * 1995-03-09 1995-10-25 孟静媛 Soybean protein food and its preparation method

Also Published As

Publication number Publication date
EP1121138A2 (en) 2001-08-08
WO2000002569A3 (en) 2001-05-17
IL125316A0 (en) 1999-03-12
WO2000002569A2 (en) 2000-01-20
CA2337753A1 (en) 2000-01-20

Similar Documents

Publication Publication Date Title
NZ514350A (en) Compositions and methods for effecting the levels of cholesterol
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
EP1143956A3 (en) Compositions and methods for the treatment of anorectal disorders
AU2951299A (en) Disinfecting compositions and processes for disinfecting surfaces
AU2212299A (en) Compositions and methods for the treatment of tumor
HUP0103920A3 (en) Methods and compositions for the prevention and treatment of anemia
AUPQ419099A0 (en) Novel compositions and methods
AU1694497A (en) Disinfecting compositions and processes for disinfecting surfaces
AU1751795A (en) Liposome compositions and methods for the treatment of atherosclerosis
AUPQ127399A0 (en) Compositions and methods for treating or preventing osteoporosis
EP1076547A4 (en) Derivatives of arabinogalactan and compositions including the same
AU2349399A (en) R-lansoprazole compositions and methods
HUP0104410A3 (en) A composition for the prevention and/or treatment of atherosclerosis
AU9016898A (en) Methods and compositions for treatment of restenosis
AU2698697A (en) Azetidinone derivatives for the treatment of atherosclerosis
AUPP589398A0 (en) Immunogenic compositions and uses thereof
AU3065999A (en) Compositions and methods for treatment of asthma
AU5249098A (en) Sprayable disinfecting compositions and processes for disinfecting surfaces therewith
AU5006499A (en) Compositions and methods for the treatment or prevention of pulmonary infections
AU2674399A (en) Compositions and methods for the inhibition of muc-5 mucin gene expression
EP1139981A4 (en) Compositions and methods of using the same
AU4440199A (en) Methods and compositions for inhibition of angiogenesis
AU4388899A (en) Novel compositions for the treatment of atherosclerosis and related conditions
AU5446798A (en) Compositions and methods for the treatment of gastrointestinal disorders
AU2221400A (en) Compositions containing and methods of using n-acyl-1h-aminoindenes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase